Purified His-tagged DEK protein was incubated with biotin-labeled probes containing the DRE1, DRE2, or HRE site, or mutated DRE1 site (DRE1-M) of the VEGF promoter, as indicated. For competition experiments, a 100-fold molar excess of unlabeled DRE1 was mixed with the biotin-labeled probe. C. EMSA assay of the DEK domain that binds to the DRE1 site of the VEGF promoter. Nuclear extracts from DEK knockdown MCF-7 cells transfected with empty vector (control), FLAG-tagged DEK or FLAG-tagged DEK deletion mutants were incubated with biotin-labeled probes containing the DRE1 site, as indicated. Western blot shows the expression of DEK and its deletion mutants with anti-FLAG. Schematic diagram of DEK and its deletion mutants is shown. SAF, scaffold attachment factor; 2nd DBD, second DNA binding domain. cotransfected with FLAG-tagged HIF-1α or FLAG-tagged HIF-1β and MYC-tagged DEK. Cell lysates were immunoprecipitated (IP) with anti-FLAG, followed by immunoblotting (IB) with the indicated antibodies. B. Co-IP assays with HEK293T cells cotransfected with MYC-tagged HIF-1α and FLAG-tagged HIF-1β with or without MYC-tagged DEK. Cell lysates were immunoprecipitated (IP) with anti-FLAG, followed by immunoblotting (IB) with the indicated antibodies. C. HEK293T cells were cotransfected with FLAG-tagged DEK and MYC-tagged HIF-1α or its deletion mutants. Cell lysates were immunoprecipitated with anti-MYC, followed by immunoblotting with the indicated antibodies. Schematic diagram of HIF-1α and its deletion mutants is shown. D. HEK293T cells were cotransfected with FLAG-tagged HIF-1β and MYC-tagged HIF-1α or its deletion mutants. Cell lysates were immunoprecipitated with anti-MYC, followed by immunoblotting with the indicated antibodies. E. HEK293T cells were cotransfected with MYC-tagged HIF-1α and FLAG-tagged HIF-1β or FLAG-tagged DEK. Cell lysates were preincubated or did not preincubate with 5 μM acriflavine and immunoprecipitated with anti-FLAG, followed by immunoblotting with the indicated antibodies. 
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